Role of quercetin on mitomycin C induced genotoxicity: Analysis of micronucleus and chromosome aberrations in vivo

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 721, Issue 2, 2011, Pages 147-152

  Mazumdar, Mehnaz ^a   Giri, Sarbani ^a   Giri, Anirudha ^a  

^a ASSAM UNIVERSITY   (India)

Author keywords

C mitosis; Chromosomal aberration; Micronucleus; Mitomycin C; Quercetin; Sticky chromosome

Indexed keywords

MITOMYCIN C; QUERCETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW CELL; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA DAMAGE; DOSE TIME EFFECT RELATION; DRUG CYTOTOXICITY; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; ERYTHROCYTE; FEMALE; GENOMIC INSTABILITY; GENOTOXICITY; IN VIVO STUDY; MALE; METAPHASE; MICRONUCLEUS; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANTIOXIDANTS; CHROMOSOME ABERRATIONS; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; INFUSIONS, PARENTERAL; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MITOMYCIN; MUTAGENS; QUERCETIN;

EID: 79952816624     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2011.01.007     Document Type: Article

References (50)

1. Ross J.A., Kasum C.M. Dietary flavonoids: bioavailability, metabolic effects and safety. Annu. Rev. Nutr. 2002, 22:19-34.
2. Kook D., Wolf A.H., Yu A.L., Neubauer A.S., Priglinger S.G., Kampik A., Welge-Lüssen U.C. The protective effect of quercetin against oxidative stress in the human RPE in vitro. Invest. Ophthalmol. Vis. Sci. 2008, 49:1712-1720.
3. Prior R.L. Fruits and vegetables in the prevention of cellular oxidative damage. Am. J. Clin. Nutr. 2003, 78:570S-578S.
4. Boots A.W., Haenen G.R.M.M., Bastm A. Health effects of quercetin: from antioxidant to nutraceutical. Eur. J. Pharmacol. 2008, 585:325-337.
5. Schlachterman A., Valle F., Wall K.M., Azios N.G., Castillo L., Morell L., Washington A.V., Cubano L.A., Dharmawardhane S.F. Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model. Transl. Oncol. 2008, 1:19-27.
6. Jin N.Z, Zhu Y.P., Zhou J.W., Mao L., Zhao R.C., Fang T.H., Wang X.R. Preventive effects of quercetin against benzo(a) pyrene-induced DNA damages and pulmonary precancerous pathologic changes in mice. Basic Clin. Pharmacol. Toxicol. 2006, 98:593-598.
7. Błasiak J. DNA-damaging effect of cadmium and protective action of quercetin. Pol. J. Environ. Stud. 2001, 10:437-442.
8. Alvi N.K., Rizvi R.Y., Hadi S.M. Interaction of quercetin with DNA. Biosci. Rep. 1986, 6:861-868.
9. Czeczot H., Tudek B., Kusztelak J., Szymczyk T., Dobrowolska B., Glinkowska G., Malinowski J., Strzelecka H. Isolation and studies of the mutagenic activity in the Ames test of flavonoids naturally occurring in medical herbs. Mutat. Res. 1990, 240:209-216.
10. Silva I.D., Gaspar J., da Costa G.G., Rodrigues A.S., Laires A., Rueff J. Chemical features of flavonols affecting their genotoxicity. Potential implications in their use as therapeutical agents. Chem. Biol. Interact. 2000, 124:29-51.
11. Duthie S.J., Johnson W., Dobson V.L. The effect of dietary flavonoids on DNA damage (strand breaks and oxidised pyrimidines) and growth in human cells. Mutat. Res. 1997, 390:141-151.
12. Crebelli R., Aquilina G., Falcone E., Carere A. Urinary and faecal mutagenicity in Sprague-Dawley rats dosed with the food mutagen quercetin and rutin. Food Chem. Toxicol. 1987, 25:9-15.
13. Rietjens I.M.C., MBoersma M.G., van der Woude H., Jeurissen S.M.F., Schutte M.E., Alink G.M. Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk. Mutat. Res. 2005, 574:124-138.
14. Duthie S.J., Dobson V.L. Dietary flavonoids protect human colonocyte DNA from oxidative attack in vitro. Eur. J. Nutr. 1999, 38:28-34.
15. Krishna G., Hayashi M. In vivo rodent micronucleus assay: protocol, conduct and data interpretation. Mutat. Res. 2000, 455:155-166.
16. Ferguson L.R. Role of plant polyphenols in genomic stability. Mutat. Res. 2001, 475:89-111.
17. Williams R.J., Spencer J.P.E., Rice-Evans C. Flavonoids: antioxidants or signalling molecules?. Free Radic. Biol. Med. 2004, 36:838-849.
18. Schmid W. The micronucleus test for cytogenetic analysis. Chemical Mutagen: Principles and Methods for their Detection 1976, vol. 4:31-53. Plenum, NY.
19. Yen G.C., Duh P.D., Tsai H.L., Huang S.L. Pro-oxidative properties of flavonoids in human lymphocytes. Biosci. Biotechnol. Biochem. 2003, 67:1215-1222.
20. Yamashita N., Tanemura H., Kawanishi S. Mechanism of oxidative DNA damage induced by quercetin in the presence of Cu(II). Mutat. Res. 1999, 425:107-115.
21. da Silva J., Herrmann S.M., Heuser V., Peres W., Possa Marroni N., González-Gallego J., Erdtmann B. Evaluation of the genotoxic effect of rutin and quercetin by comet assay and micronucleus test. Food Chem. Toxicol. 2002, 40:941-947.
22. Utesch D., Feige K., Dasenbrock J., Broschard T.H., Harwood M., Danielewska-Nikiel B., Lines T.C. Evaluation of the potential in vivo genotoxicity of quercetin. Mutat. Res. 2008, 654:38-44.
23. Sahu S.C., Gray G.C. Lipid peroxidation and DNA damage induced by morin and naringenin in isolated rat liver nuclei. Food Chem. Toxicol. 1997, 35:443-447.
24. +-bound oligomers of quercetin in the gas phase. Rapid Commun. Mass Spectrom. 2000, 14:2154-2157.
25. Omenn G.S. Micronutrients (Vitamins and Minerals) as Cancer-preventive Agents 1997, vol. 139. IARC Sci. Publ., pp. 33-45.
26. Boots A.W., Li H., Schins R.P.F., Duffin R., Heemskerk J.W.M., Bast A., Haenen G.R.M.M. The quercetin paradox. FEBS Lett. 2007, 222:89-96.
27. Spencer J.P.E., Kuhnle G.G.C., Williams R.J., Rice-Evans C. Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochem. J. 2003, 372:173-181.
28. Metodiewa D., Jaiswal A.K., Cenas N., Dickancaite E., Segura-Aguilar J. Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic. Biol. Med. 1999, 26:107-116.
29. Walle T., Vincent T.S., Walle U.K. Evidence of covalent binding of the dietary flavonoid quercetin to DNA and protein in human intestinal and hepatic cells. Biochem. Pharmacol. 2003, 65:1603-1610.
30. Castillo M.H., Perkins E., Campbell J.H., Doerr R., Hassett J.M., Kandaswami C., Middleton E. The effects of the bioflavonoid quercetin on squamous cell carcinoma of head and neck origin. Am. J. Surg. 1989, 158:351-355.
31. Albertini R.J., Aderson D., Dauglas G.R., Hagmar L., Hemminki K., Merlo F., Natarajan A.T., Norppa H., Shuker D.E.G., Tice R., Waters M.D., Aitio A. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in human. Mutat. Res. 2000, 463:111-172.
32. Cantero G., Campanella C., Mateos S., Corteós F. Topoisomerase II inhibition and high yield of endoreduplication induced by the flavonoids luteolin and quercetin. Mutagenesis 2006, 21:321-325.
33. Ibrulj S., Efendic-Tasevac A. Mitotic abnormalities induced by oxazepam in the culture of human lymphocytes. Acta Pharm. 2002, 52:61-66.
34. Graf B.A., Ameho C., Dolnikowski G.G., Milbury P.E., Chen C.-Y., Blumberg B. Rat gastrointestinal tissues metabolize quercetin. J. Nutr. 2006, 136:39-44.
35. Day A.J., Williamson G. Absorption of quercetin glycosides. Flavonoids in Health and Disease 2003, 31-412. Marcel Dekker, New York. C. Rice-Evans, L. Packer (Eds.).
36. Awad H.M., Boersma M.G., Boeren S., van Bladeren P.J., Vervoort J., Rietjens I.M. The regioselectivity of glutathione adduct formation with flavonoid quinone/quinone methides is pH-dependent. Chem. Res. Toxicol. 2002, 15:343-351.
37. Monks T.J., Lau S.S. The pharmacology and toxicology of polyphenolic-glutathione conjugates. Annu. Rev. Pharmacol. Toxicol. 1998, 38:229-255.
38. Bolton J.L. Quinoids, quinoid radicals, and phenoxyl radicals formed from estrogens and antiestrogens. Toxicology 2002, 177:55-65.
39. Ishikawa T The ATP-dependent glutathione S-conjugate export pump. Trends Biochem. Sci. 1992, 17:463-468.
40. Spencer J.P.E., Jenner P., Halliwell B. Superoxide-dependent depletion of reduced glutathione by l-DOPA and dopamine. Relevance to Parkinson's disease. Neuroreport 1995, 6:1480-1484.
41. Devipriya N., Sudheer A.R., Srinivasan M., Menon V.P. Quercetin ameliorates gamma radiation-induced DNA damage and biochemical changes in human peripheral blood lymphocytes. Mutat. Res. 2008, 654:1-7.
42. 2-induced DNA single-strand breaks in Caco-2, Hep G2, and V79 cells. Nutr. Cancer 2000, 38:106-115.
43. Møller P., Vogel U., Pedersen A., Dragsted L.O., Sandstrom B., Loft S. No effect of 600 grams fruit and vegetables per day on oxidative DNA damage and repair in healthy nonsmokers. Cancer Epidemiol. Biomarkers Prev. 2003, 12:1016-1022.
44. Fritsche M., Haessler C., Brandner G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNAdamaging agents. Oncogene 1993, 8:307-318.
45. Wu K.-Y., Wang H.-Z. Show-jen hong mechanism of mitomycin-induced apoptosis in cultured corneal endothelial cells. Mol. Vision 2008, 14:1705-1712.
46. Tanigawa S., Fujii M., Hou D.-X. Stabilization of p53 is involved in quercetin-induced cell cycle arrest and apoptosis in HepG2 cells. Biosci. Biotechnol. Biochem. 2008, 72:797-804.
47. Haghiac M., Walle T. Quercetin induces necrosis and apoptosis in SCC-9 oral cancer cells. Nutr. Cancer 2008, 53:220-231.
48. Ferguson L.R., Whiteside G., Holdaway K.M., Baguley B.C. Application of fluorescence in situ hybridisation to studying the relationship between cytotoxicity, chromosomal aberrations and changes in chromosome number after treatment with the topoisomerase II inhibitor, amsacrine. Environ. Mol. Mutagen. 1996, 27:255-262.
49. Hofmann J., Fiebig H.H., Winterhalter B.R., Berger D.P., Grunicke H. Enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by quercetin. Int. J. Cancer 1990, 45:536-539.
50. Hoffman R., Graham L., Newlands E.S. Enhanced anti-proliferative action of busulphan by quercetin on the human leukaemia cell line K562. Br. J. Cancer 1989, 59:347-348.